{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:05:55Z","timestamp":1787166355776,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1124\/jpet.105.097402","type":"journal-article","created":{"date-parts":[[2006,4,17]],"date-time":"2006-04-17T18:48:39Z","timestamp":1145299719000},"page":"667-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Role of Site-Specific Binding to Plasma Albumin in Drug Availability to Brain"],"prefix":"10.1016","volume":"317","author":[{"given":"Haritha","family":"Mandula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagan Mohan R.","family":"Parepally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.097402_bib1","doi-asserted-by":"crossref","unstructured":"Adkison KD and Shen DD (1996) Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter. J Pharmacol Exp Ther 276: 1189\u20131200.","DOI":"10.1016\/S0022-3565(25)12397-5"},{"key":"10.1124\/jpet.105.097402_bib2","doi-asserted-by":"crossref","unstructured":"Barre J, Chamouard JM, Houin G, and Tillement JP (1985) Equilibrium dialysis, ultrafiltration and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid. Clin Chem 31: 60\u201364.","DOI":"10.1093\/clinchem\/31.1.60"},{"key":"10.1124\/jpet.105.097402_bib3","doi-asserted-by":"crossref","unstructured":"Begley DJ and Brightman MW (2003) Structural and functional aspects of the blood-brain barrier. Prog Drug Res 61: 39\u201378.","DOI":"10.1007\/978-3-0348-8049-7_2"},{"key":"10.1124\/jpet.105.097402_bib4","unstructured":"Buxton I (2005) Pharmacokinetics and pharmacodynamics: the dynamics of drug absorption, distribution, action and elimination, in Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics (Brunton L ed) pp 1\u201339, McGraw-Hill, Chicago."},{"key":"10.1124\/jpet.105.097402_bib5","unstructured":"Crone C and Levitt DG (1984) Capillary permeability to small solutes, in Handbook of Physiology: The Cardiovascular System. Microcirculation (Renkin EM and Michel CC eds) pp 411\u2013466, American Physiological Society, Bethesda, MD."},{"key":"10.1124\/jpet.105.097402_bib6","doi-asserted-by":"crossref","unstructured":"Dubey RK, McAllister CB, Inoue M, and Wilkinson GR (1989) Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation. J Clin Investig 84: 1155\u20131159.","DOI":"10.1172\/JCI114279"},{"key":"10.1124\/jpet.105.097402_bib7","doi-asserted-by":"crossref","unstructured":"Duelli R and Kuschinsky W (1993) Changes in brain capillary diameter during hypocapnia and hypercapnia. J Cereb Blood Flow Metab 13: 1025\u20131028.","DOI":"10.1038\/jcbfm.1993.129"},{"key":"10.1124\/jpet.105.097402_bib8","doi-asserted-by":"crossref","unstructured":"Fehske KJ, Schlafer U, Wollert U, and Muller WE (1982) Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Mol Pharmacol 21: 387\u2013393.","DOI":"10.1016\/S0026-895X(25)14614-2"},{"key":"10.1124\/jpet.105.097402_bib9","doi-asserted-by":"crossref","unstructured":"Fenerty CA and Lindup WE (1989) Brain uptake of l-tryptophan and diazepam: the role of plasma protein binding. J Neurochem 53: 416\u2013422.","DOI":"10.1111\/j.1471-4159.1989.tb07350.x"},{"key":"10.1124\/jpet.105.097402_bib10","doi-asserted-by":"crossref","unstructured":"Hawkins BT and Davis TP (2005) The blood-brain barrier\/neurovascular unit in health and disease. Pharmacol Rev 57: 173\u2013185.","DOI":"10.1124\/pr.57.2.4"},{"key":"10.1124\/jpet.105.097402_bib11","doi-asserted-by":"crossref","unstructured":"Jones DR, Hall SD, Jackson EK, Branch RA, and Wilkinson GR (1988) Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding. J Pharmacol Exp Ther 245: 816\u2013822.","DOI":"10.1016\/S0022-3565(25)24108-8"},{"key":"10.1124\/jpet.105.097402_bib12","doi-asserted-by":"crossref","unstructured":"Kosa T, Maruyama T, and Otagiri M (1997) Species differences of serum albumins: I. Drug binding sites. Pharm Res (NY) 14: 1607\u20131612.","DOI":"10.1023\/A:1012138604016"},{"key":"10.1124\/jpet.105.097402_bib13","doi-asserted-by":"crossref","unstructured":"Kragh-Hansen U, Chuang VT, and Otagiri M (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 25: 695\u2013704.","DOI":"10.1248\/bpb.25.695"},{"key":"10.1124\/jpet.105.097402_bib14","doi-asserted-by":"crossref","unstructured":"Kratochwil NA, Huber W, Muller F, Kansy M, and Gerber PR (2002) Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol 64: 1355\u20131374.","DOI":"10.1016\/S0006-2952(02)01074-2"},{"key":"10.1124\/jpet.105.097402_bib15","doi-asserted-by":"crossref","unstructured":"Lin TH and Lin JH (1990) Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats. J Pharmacol Exp Ther 253: 45\u201350.","DOI":"10.1016\/S0022-3565(25)12479-8"},{"key":"10.1124\/jpet.105.097402_bib16","doi-asserted-by":"crossref","unstructured":"Loun B and Hage DS (1994) Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. Anal Chem 66: 3814\u20133822.","DOI":"10.1021\/ac00093a043"},{"key":"10.1124\/jpet.105.097402_bib17","unstructured":"Mandula H, Parepally JR, Hage D, and Smith QR (2005) Role of specific plasma protein binding sites on drug uptake into brain (Abstract), in 2005 Society for Neuroscience Annual Meeting; 2005 Nov 12\u201316; Washington DC. Program 190.11, Abstract Viewer and Itinerary Planner online, Society for Neuroscience, Washington DC."},{"key":"10.1124\/jpet.105.097402_bib18","doi-asserted-by":"crossref","unstructured":"March C and Blanke RV (1985) Determination of free valproic acid concentrations using the Amicon micropartition MPS-1 ultrafiltration system. Ther Drug Monit 7: 115\u2013120.","DOI":"10.1097\/00007691-198503000-00020"},{"key":"10.1124\/jpet.105.097402_bib19","doi-asserted-by":"crossref","unstructured":"Morgan DJ and Huang JL (1993) Effect of plasma protein binding on kinetics of capillary uptake and efflux. Pharm Res (NY) 10: 300\u2013304.","DOI":"10.1023\/A:1018959415963"},{"key":"10.1124\/jpet.105.097402_bib20","doi-asserted-by":"crossref","unstructured":"Ohno K, Pettigrew KD, and Rapoport SI (1978) Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 235: H299\u2013H307.","DOI":"10.1152\/ajpheart.1978.235.3.H299"},{"key":"10.1124\/jpet.105.097402_bib21","doi-asserted-by":"crossref","unstructured":"Pardridge WM (1998) Targeted delivery of hormones to tissues by plasma proteins, in Handbook of Physiology Section 7: The Endocrine System (Conn PM ed) pp 335\u2013382, Oxford University Press, Oxford.","DOI":"10.1002\/cphy.cp070114"},{"key":"10.1124\/jpet.105.097402_bib22","doi-asserted-by":"crossref","unstructured":"Pardridge WM (2001) Brain Drug Targeting: The Future of Brain Drug Development. Cambridge University Press, Cambridge.","DOI":"10.1017\/CBO9780511549571"},{"key":"10.1124\/jpet.105.097402_bib23","doi-asserted-by":"crossref","unstructured":"Pardridge WM and Landaw EM (1984) Tracer kinetic model of blood-brain barrier transport of plasma protein-bound ligands. Empiric testing of the free hormone hypothesis. J Clin Investig 74: 745\u2013752.","DOI":"10.1172\/JCI111490"},{"key":"10.1124\/jpet.105.097402_bib24","unstructured":"Peters T (1996) All about Albumin: Biochemistry, Genetics and Medical Applications. Academic Press, Inc., San Diego, CA."},{"key":"10.1124\/jpet.105.097402_bib25","doi-asserted-by":"crossref","unstructured":"Petitpas I, Bhattacharya AA, Twine S, East M, and Curry S (2001) Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J Biol Chem 276: 22804\u201322809.","DOI":"10.1074\/jbc.M100575200"},{"key":"10.1124\/jpet.105.097402_bib26","doi-asserted-by":"crossref","unstructured":"Robinson PJ (1990) Measurement of blood-brain barrier permeability. Clin Exp Pharmacol Physiol 17: 829\u2013840.","DOI":"10.1111\/j.1440-1681.1990.tb01286.x"},{"key":"10.1124\/jpet.105.097402_bib27","doi-asserted-by":"crossref","unstructured":"Seller EM, Lang-Sellers ML, and Koch-Weser J (1977) Comparative warfarin binding to albumin from various species. Biochem Pharmacol 26: 2445\u20132447.","DOI":"10.1016\/0006-2952(77)90455-5"},{"key":"10.1124\/jpet.105.097402_bib28","doi-asserted-by":"crossref","unstructured":"Sjoholm I, Ekman B, Kober A, Ljungstedt-Pahlman I, Seiving B, and Sjodin T (1979) Binding of drugs to human serum albumin: I. The specificity of three binding sites as studied with albumin immobilized in microparticles. Mol Pharmacol 16: 767\u2013777.","DOI":"10.1016\/S0026-895X(25)13820-0"},{"key":"10.1124\/jpet.105.097402_bib29","doi-asserted-by":"crossref","unstructured":"Smith QR (1996) Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system. Pharm Biotechnol 8: 285\u2013307.","DOI":"10.1007\/978-1-4899-1863-5_15"},{"key":"10.1124\/jpet.105.097402_bib30","doi-asserted-by":"crossref","unstructured":"Smith QR (2003) A review of blood-brain barrier transport techniques. Methods Mol Med 89: 193\u2013208.","DOI":"10.1385\/1-59259-419-0:193"},{"key":"10.1124\/jpet.105.097402_bib31","doi-asserted-by":"crossref","unstructured":"Smith QR and Nagura H (2001) Fatty acid uptake and incorporation in brain: studies with the perfusion model. J Mol Neurosci 16: 167\u2013172.","DOI":"10.1385\/JMN:16:2-3:167"},{"key":"10.1124\/jpet.105.097402_bib32","doi-asserted-by":"crossref","unstructured":"Sudlow G, Birkett DJ, and Wade DN (1975) The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11: 824\u2013832.","DOI":"10.1016\/S0026-895X(25)10691-3"},{"key":"10.1124\/jpet.105.097402_bib33","doi-asserted-by":"crossref","unstructured":"Takasato Y, Rapoport SI, and Smith QR (1984) An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 247: H484\u2013H493.","DOI":"10.1152\/ajpheart.1984.247.3.H484"},{"key":"10.1124\/jpet.105.097402_bib34","doi-asserted-by":"crossref","unstructured":"Talbert AM, Tranter GE, Holmes E, and Francis PL (2002) Determination of drug-plasma protein binding kinetics and equilibria by chromatographic profiling: exemplification of the method using l-tryptophan and albumin. Anal Chem 74: 446\u2013452.","DOI":"10.1021\/ac010643c"},{"key":"10.1124\/jpet.105.097402_bib35","doi-asserted-by":"crossref","unstructured":"Tanaka H and Mizojiri K (1999) Drug-protein binding and blood-brain barrier permeability. J Pharmacol Exp Ther 288: 912\u2013918.","DOI":"10.1016\/S0022-3565(24)38041-3"},{"key":"10.1124\/jpet.105.097402_bib36","doi-asserted-by":"crossref","unstructured":"Urien S, Morin D, and Tillement JP (1989) Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats. J Pharmacol Exp Ther 248: 781\u2013785.","DOI":"10.1016\/S0022-3565(25)23771-5"},{"key":"10.1124\/jpet.105.097402_bib37","doi-asserted-by":"crossref","unstructured":"Videbaek C, Ott P, Paulson OB, and Knudsen GM (1999) Blood-brain barrier transport and protein binding of flumazenil and iomazenil in the rat: implications for neuroreceptor studies. J Cereb Blood Flow Metab 19: 948\u2013955.","DOI":"10.1097\/00004647-199909000-00002"},{"key":"10.1124\/jpet.105.097402_bib38","doi-asserted-by":"crossref","unstructured":"Yang J and Hage DS (1997) Effect of mobile phase composition on the binding kinetics of chiral solutes on a protein-based high-performance liquid chromatography column: interactions of d- and l-tryptophan with immobilized human serum albumin. J Chromatogr A 766: 15\u201325.","DOI":"10.1016\/S0021-9673(96)01040-0"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524326564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524326564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.097402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:51:08Z","timestamp":1739983868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524326564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0022356524326564"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.097402","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Site-Specific Binding to Plasma Albumin in Drug Availability to Brain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.097402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}